Trk1/2/3 inhibitor(Shenzhen TargetRx)

N/A

Report date: 2025/12/01 11:39:54
NME

Base Information

Drug NameTrk1/2/3 inhibitor(Shenzhen TargetRx)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionNerve growth factor receptor Trk-A inhibitorsNeurotrophic tyrosine kinase receptor type 2 inhibitorsNeurotrophic tyrosine kinase receptor type 3 inhibitors
TargetsNerve growth factor receptor Trk-ANeurotrophic tyrosine kinase receptor type 2Neurotrophic tyrosine kinase receptor type 3
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShenzhen TargetRx Inc
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen TargetRx Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A